LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/All-In-One Pedicle Screw System from DePuy Synthes
Spine

All-In-One Pedicle Screw System from DePuy Synthes

November 9, 2015 2 min read Premium comments

Advertisement

All-In-One Pedicle Screw System from DePuy Synthes
Expedium Verse Spinal System / Courtesy of DePuy Synthes Spine
Secondary

DePuy Synthes Spine has a new all-in-one pedicle screw system called the Expedium Verse Spinal System.

By potentially reducing the number of screws needed in a procedure, the company claims the Expedium system allows surgeons to perform multiple maneuvers during fusion surgery with a single implant type and fewer instruments.

The system touts an innovative “Correction Key” which enables conversion to multiple screw types, “which expands implant functionality, provides interorperative flexibility” and therefore offers the possibility of fewer screws. The number of instrument trays per procedure can be reduced to as few as four and helps reduce sterilization costs by 84%. With these features, the company hopes to reduce procedure time.

Suken A. Shah, M.D., division chief, Spine and Scoliosis Center, Nemours/Alfred I duPont Hospital for Children, Wilmington, Delaware, believes the system, “may fundamentally change the way surgeons approach scoliosis by offering any number of ways to engage the rod and derotate the spine in order to truly achieve three dimensional correction. Set consolidation and limited need for ancillary instruments improve operating room efficiency and provide additional value for the hospital through easier adoption, faster turnover, and less sterilization demands.”

According to the company, increased screw head angulation and reduction tabs optimize rod placement and “may help reduce over-bending of the rod during implantation, which can lead to rod fatigue.” In addition, improved control over screw positioning and improved distribution of forces “may help reduce the risk of screw pullout or migration when compared to traditional screws.” When used to treat degenerative disorders of the mid- and lower-back, the increased angulation of the Expedium pedicle screw “may allow for less tissue retraction.”

Scale and Value

DePuy Synthes Spine’s platform leader, Dan Wildman said the company’s goal was to develop an implant-based system that would benefit patients while supporting procedural efficiency and value. “We have achieved that goal.”

The company also has scale in mind by selling the Expedium as part of a comprehensive package that provides hospitals with a single source to address complex spine needs. In collaboration with Ethicon, the company is offering the Harmonic Osteovue Spine Soft Tissue Dissector exclusively to spine surgeons, who also have access to Stratafix Symmetric PDS Synthetic Absorbable Sutures for suture closure and Dermabond Prineo for wound closure. Externally, the company is working with Brainlab to offer distinct navigation solutions and with LifeNet Health to offer ViviGen Cellular Bone Matrix (one of the 2015 Orthopedics This Week Spine Technology Award winners).

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy